nodes	percent_of_prediction	percent_of_DWPC	metapath
Progabide—GABBR1—GPCRs, Class C Metabotropic glutamate, pheromone—GRM4—Parkinson's disease	0.0622	0.0709	CbGpPWpGaD
Progabide—GABBR1—Activation of G protein gated Potassium channels—KCNJ4—Parkinson's disease	0.058	0.0661	CbGpPWpGaD
Progabide—GABBR1—GPCRs, Class C Metabotropic glutamate, pheromone—GRM5—Parkinson's disease	0.0501	0.0571	CbGpPWpGaD
Progabide—GABBR1—Inwardly rectifying K+ channels—KCNJ4—Parkinson's disease	0.0488	0.0557	CbGpPWpGaD
Progabide—GABBR1—Activation of GABAB receptors—KCNJ4—Parkinson's disease	0.0415	0.0473	CbGpPWpGaD
Progabide—GABBR1—GABA receptor activation—KCNJ4—Parkinson's disease	0.0318	0.0362	CbGpPWpGaD
Progabide—GABBR1—Potassium Channels—HCN3—Parkinson's disease	0.0299	0.0341	CbGpPWpGaD
Progabide—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM4—Parkinson's disease	0.0284	0.0323	CbGpPWpGaD
Progabide—GABBR1—Class C/3 (Metabotropic glutamate/pheromone receptors)—GRM5—Parkinson's disease	0.0229	0.0261	CbGpPWpGaD
Progabide—GABBR1—Potassium Channels—KCNJ4—Parkinson's disease	0.0193	0.022	CbGpPWpGaD
Progabide—GABRA1—hindbrain—Parkinson's disease	0.0146	0.119	CbGeAlD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.0146	0.0167	CbGpPWpGaD
Progabide—GABBR1—medulla oblongata—Parkinson's disease	0.0133	0.108	CbGeAlD
Progabide—GABBR1—Neuronal System—HCN3—Parkinson's disease	0.0131	0.0149	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.0126	0.0144	CbGpPWpGaD
Progabide—GABBR1—midbrain—Parkinson's disease	0.0122	0.0991	CbGeAlD
Progabide—GABBR1—spinal cord—Parkinson's disease	0.0119	0.0967	CbGeAlD
Progabide—GABRA1—GABA receptor activation—KCNJ4—Parkinson's disease	0.0111	0.0126	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.011	0.0125	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00987	0.0113	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00949	0.0108	CbGpPWpGaD
Progabide—GABBR1—cerebellum—Parkinson's disease	0.00941	0.0767	CbGeAlD
Progabide—GABBR1—Neuronal System—KCNJ4—Parkinson's disease	0.00842	0.0096	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.0084	0.00957	CbGpPWpGaD
Progabide—GABRA1—brainstem—Parkinson's disease	0.00839	0.0684	CbGeAlD
Progabide—GABRA1—forebrain—Parkinson's disease	0.0081	0.066	CbGeAlD
Progabide—GABBR1—brain—Parkinson's disease	0.00764	0.0623	CbGeAlD
Progabide—GABBR1—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00742	0.00846	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—DLG1—Parkinson's disease	0.00727	0.00828	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—GRM4—Parkinson's disease	0.00688	0.00785	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—PENK—Parkinson's disease	0.00652	0.00744	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00645	0.00735	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00643	0.00733	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00631	0.00719	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—GPR37—Parkinson's disease	0.00613	0.00699	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00611	0.00697	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—PDYN—Parkinson's disease	0.00597	0.0068	CbGpPWpGaD
Progabide—GABRA1—medulla oblongata—Parkinson's disease	0.00585	0.0477	CbGeAlD
Progabide—GABBR1—Neuronal System—GRIK1—Parkinson's disease	0.00569	0.00648	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00554	0.00631	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00541	0.00617	CbGpPWpGaD
Progabide—GABRA1—midbrain—Parkinson's disease	0.00535	0.0436	CbGeAlD
Progabide—GABRA1—spinal cord—Parkinson's disease	0.00522	0.0425	CbGeAlD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ4—Parkinson's disease	0.00509	0.0058	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00489	0.00557	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00484	0.00551	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—GRIK2—Parkinson's disease	0.00484	0.00551	CbGpPWpGaD
Progabide—GABRA1—Ion channel transport—TRPM7—Parkinson's disease	0.00474	0.00541	CbGpPWpGaD
Progabide—GABRA1—Ion channel transport—ATP1A3—Parkinson's disease	0.00474	0.00541	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—SLC18A2—Parkinson's disease	0.00468	0.00534	CbGpPWpGaD
Progabide—GABRA1—head—Parkinson's disease	0.00464	0.0378	CbGeAlD
Progabide—GABRA1—Neuronal System—HCN3—Parkinson's disease	0.00455	0.00518	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00443	0.00505	CbGpPWpGaD
Progabide—GABRA1—nervous system—Parkinson's disease	0.0044	0.0358	CbGeAlD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG1—Parkinson's disease	0.00439	0.00501	CbGpPWpGaD
Progabide—GABRA1—central nervous system—Parkinson's disease	0.00423	0.0345	CbGeAlD
Progabide—GABBR1—GPCR ligand binding—GRM4—Parkinson's disease	0.00417	0.00475	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00416	0.00474	CbGpPWpGaD
Progabide—GABRA1—cerebellum—Parkinson's disease	0.00414	0.0337	CbGeAlD
Progabide—GABBR1—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.00409	0.00467	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00407	0.00464	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00401	0.00457	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—PENK—Parkinson's disease	0.00395	0.0045	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—DRD3—Parkinson's disease	0.00383	0.00436	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.00382	0.00436	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—CHRNA4—Parkinson's disease	0.00371	0.00422	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—PDYN—Parkinson's disease	0.00361	0.00412	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00346	0.00395	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—DRD2—Parkinson's disease	0.00346	0.00395	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Parkinson's disease	0.00344	0.00392	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00341	0.00389	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—HSPA8—Parkinson's disease	0.0034	0.00387	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00338	0.00386	CbGpPWpGaD
Progabide—GABRA1—brain—Parkinson's disease	0.00336	0.0274	CbGeAlD
Progabide—GABBR1—GPCR ligand binding—GRM5—Parkinson's disease	0.00336	0.00383	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.0033	0.00376	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—DLG4—Parkinson's disease	0.00319	0.00363	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00315	0.00359	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GPR37—Parkinson's disease	0.00315	0.00359	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—GRIN2B—Parkinson's disease	0.00312	0.00355	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—SLC6A3—Parkinson's disease	0.00307	0.0035	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00305	0.00348	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—KCNJ4—Parkinson's disease	0.00293	0.00334	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Parkinson's disease	0.00292	0.00333	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00288	0.00328	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00286	0.00326	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00263	0.00299	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—COMT—Parkinson's disease	0.00261	0.00298	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—MAOA—Parkinson's disease	0.00259	0.00296	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.00258	0.00294	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—DLG1—Parkinson's disease	0.00253	0.00288	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00248	0.00282	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—TAC1—Parkinson's disease	0.00244	0.00278	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—DRD1—Parkinson's disease	0.00239	0.00273	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GRK5—Parkinson's disease	0.00238	0.00272	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00235	0.00268	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—DRD3—Parkinson's disease	0.00232	0.00264	CbGpPWpGaD
Progabide—GABRA1—Orphan transporters—CYCS—Parkinson's disease	0.00226	0.00258	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—VPS35—Parkinson's disease	0.00224	0.00256	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.00224	0.00255	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PENK—Parkinson's disease	0.00223	0.00254	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.0022	0.0025	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GRM4—Parkinson's disease	0.00214	0.00244	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00213	0.00242	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—HTR7—Parkinson's disease	0.0021	0.00239	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—DRD2—Parkinson's disease	0.0021	0.00239	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00205	0.00234	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00204	0.00233	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PENK—Parkinson's disease	0.00203	0.00231	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—GRIK1—Parkinson's disease	0.00198	0.00226	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00198	0.00225	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00195	0.00222	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.00193	0.0022	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GRM5—Parkinson's disease	0.0019	0.00216	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00188	0.00215	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GPR37—Parkinson's disease	0.00186	0.00212	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—DGKQ—Parkinson's disease	0.00186	0.00212	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PDYN—Parkinson's disease	0.00185	0.00211	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GRM5—Parkinson's disease	0.00172	0.00196	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.0017	0.00194	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.0017	0.00194	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.00168	0.00192	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—GRIK2—Parkinson's disease	0.00168	0.00192	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—EDN1—Parkinson's disease	0.00168	0.00191	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00165	0.00188	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00165	0.00188	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	0.00163	0.00186	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00161	0.00184	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.00154	0.00176	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—RIT2—Parkinson's disease	0.00149	0.00169	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00147	0.00167	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00147	0.00167	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00145	0.00165	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00144	0.00164	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.00142	0.00161	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GRK5—Parkinson's disease	0.00141	0.00161	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.0014	0.0016	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.00139	0.00159	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00139	0.00158	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00138	0.00157	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00135	0.00154	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—DRD3—Parkinson's disease	0.00131	0.00149	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	0.00129	0.00147	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00127	0.00145	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GRM4—Parkinson's disease	0.00126	0.00144	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—TAC1—Parkinson's disease	0.00125	0.00143	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00123	0.0014	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—DRD1—Parkinson's disease	0.00123	0.0014	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00122	0.00139	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PENK—Parkinson's disease	0.0012	0.00137	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MAG—Parkinson's disease	0.0012	0.00137	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—DRD3—Parkinson's disease	0.00119	0.00136	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.00119	0.00135	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—HTR7—Parkinson's disease	0.00118	0.00135	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—DRD2—Parkinson's disease	0.00118	0.00135	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.00118	0.00135	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.00118	0.00134	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00117	0.00133	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00111	0.00127	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.00111	0.00126	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PDYN—Parkinson's disease	0.0011	0.00125	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.00108	0.00124	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—DRD2—Parkinson's disease	0.00108	0.00123	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—HTR7—Parkinson's disease	0.00108	0.00123	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.00107	0.00122	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GFAP—Parkinson's disease	0.00103	0.00117	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GRM5—Parkinson's disease	0.00102	0.00116	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000948	0.00108	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000909	0.00104	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000902	0.00103	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FGF20—Parkinson's disease	0.000893	0.00102	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000876	0.000999	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000866	0.000987	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—EDN1—Parkinson's disease	0.000861	0.000982	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00083	0.000946	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000806	0.000919	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—INSR—Parkinson's disease	0.000799	0.000911	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FGB—Parkinson's disease	0.000755	0.000861	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000753	0.000859	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000751	0.000856	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—TAC1—Parkinson's disease	0.00074	0.000843	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—DRD1—Parkinson's disease	0.000726	0.000827	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—DRD3—Parkinson's disease	0.000703	0.000801	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000694	0.000791	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000692	0.000789	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000656	0.000748	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—DRD2—Parkinson's disease	0.000635	0.000724	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HTR7—Parkinson's disease	0.000635	0.000724	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000575	0.000655	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000552	0.000629	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IGF2—Parkinson's disease	0.000533	0.000607	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000515	0.000587	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—EDN1—Parkinson's disease	0.000509	0.00058	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000504	0.000574	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00048	0.000547	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—NGF—Parkinson's disease	0.000468	0.000533	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00046	0.000525	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HTR2A—Parkinson's disease	0.000445	0.000507	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—APOE—Parkinson's disease	0.000414	0.000472	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000406	0.000463	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—INS—Parkinson's disease	0.000353	0.000403	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CASP3—Parkinson's disease	0.000263	0.0003	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—IL6—Parkinson's disease	0.000261	0.000298	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MAPK8—Parkinson's disease	0.000242	0.000276	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IL6—Parkinson's disease	0.000154	0.000176	CbGpPWpGaD
